Schoenbrunn, Germany

Joris Braspenning

This inventor holds 1 USPTO granted patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joris Braspenning. Retrieved from https://idiyas.com/inventor/joris-braspenning

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joris Braspenning: Innovator in HPV Research

Introduction

Joris Braspenning is a notable inventor based in Schonbrunn, Germany. He has made significant contributions to the field of medical research, particularly in the detection of specific antibodies related to HPV proteins. His work is crucial in advancing our understanding of human papillomavirus and its implications for health.

Latest Patents

Joris Braspenning holds a patent for a "Process for detecting specific antibodies acting against HPV proteins." This innovation is vital for developing diagnostic tools that can help in the early detection of HPV-related conditions.

Career Highlights

He is currently affiliated with the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts, where he continues to engage in groundbreaking research. His dedication to cancer research and HPV detection has positioned him as a key figure in the scientific community.

Collaborations

Throughout his career, Joris has collaborated with esteemed colleagues such as Hanswalter Zentgraf and Manfred Frey. These partnerships have enhanced the quality and impact of his research.

Conclusion

Joris Braspenning's contributions to HPV research through his innovative patent and collaborations highlight his importance in the field of medical science. His work continues to pave the way for advancements in cancer detection and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…